Comorbidities Drive Outcomes for Both Malignancy-Associated and Non-Malignancy-Associated Hemophagocytic Syndrome.


BACKGROUND Secondary hemophagocytic syndrome (SHPS) is a syndrome that develops as a result of infection, autoimmunity, or underlying malignancy. We studied novel predictors of mortality among adults with SHPS. PATIENTS AND METHODS SHPS were identified from the Nationwide Inpatient Sample for 2009 to 2011 using International Classification of Diseases… (More)
DOI: 10.1016/j.clml.2016.01.002


  • Presentations referencing similar topics